Impressive results from “game-changing” mRNA skin cancer vaccine trial
The first results from a trial testing mRNA technology against cancer reveal 44% of patients fared better than those on conventional treatments. The announcement from Moderna reveals Phase 3 trials for its mRNA skin cancer vaccine will commence next year. Source of Article